(E)-2-(3-Chlorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

methyl 3-{[2-(dimethylamino)ethyl]amino}-2-methylpropanoate, 95.0%, 2g

(4S)-4-N-Fmoc-amino-1-Boc-L-proline, 97.0%, 5g

DL-Tryptophane, min.98%, pour la biochimie, 10 g, emballage plastique.

1-Methylpiperidine-4-carboxylic Acid>98.0%(GC)(T)5g

C6 Ceramide, 98%, 250mg

[1,1':4',1''-Terphenyl]-4,4''-dicarboxylic Acid, 95.0%, 1g

1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride, 95.0%, 250mg

(4-((4-Methoxybenzyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

5-Amino-2-methylbenzoic acid, 97.0%, 25g

1,4,7-Trithionane, 98%, 500mg

Systèmes de dialyse Spectra/Por® Float-A-Lyzer® G2 Volume de remplissage 10 ml, 100000 dalton(s), 12 pièce(s)

5-(4-chlorophenyl)-4-hydrazinylthieno[2,3-d]pyrimidine, 95.0%, 250mg